We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.50
Bid: 68.00
Ask: 69.00
Change: 2.50 (3.76%)
Spread: 1.00 (1.471%)
Open: 68.00
High: 69.00
Low: 65.50
Prev. Close: 66.50
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Awards under LTIP

28 Jul 2023 07:00

RNS Number : 4811H
TruFin PLC
28 July 2023
 

28 July 2023

TruFin plc("TruFin" or the "Company")

Grant of share awards under Long Term Incentive Plan

As referred to in TruFin's announcement on 22 June 2023, the Company announces that it has now adopted a new Long Term Incentive plan (the "LTIP"). The LTIP has been implemented to appropriately incentivise key individuals over the long term, driving retention and performance.

 

The Company's intention is to operate the LTIP as a four-year programme of awards, with awards vesting in four tranches from 31 December 2023 and each anniversary of that date until 31 December 2026.

 

Therefore, on 27 July 2023, the Company awarded the first three tranches of awards under the LTIP. These are in the form of options over a total of 3,116,667 Ordinary Shares (the "Options") to the Chief Executive Officer and other senior employees.

 

The Options will vest in three tranches from 31 December 2023 and the anniversaries of that date up to and including 31 December 2025. Save for the first tranche of Options that vest on 31 December 2023, vesting of the Options granted to James van den Bergh (CEO) and James Hussey (CFO) are subject to performance criteria set by the Remuneration Committee of the Company based on a share price performance metric. In addition to this metric, Options granted to subsidiary company CEOs are subject to subsidiary company financial performance metrics. The Options expire 10 years post grant date.

 

The Company's intention is to grant the fourth tranche of options in early 2024, following the announcement of the Company's results for the 2023 financial year, subject to the same performance metrics as the second and third tranches of the Options but with a vesting date of 31 December 2026 (the "Tranche 4 Options").

 

Details of the grants of Options and the proposed grant of Tranche 4 Options to PDMRs are set out below:

 

Name

Position

Options granted

Tranche 4 Options (not yet granted)

Tranche 1

Tranche 2

Tranche 3

Tranche 4

James van den Bergh

Chief Executive Officer

300,000

300,000

300,000

300,000

James Hussey

Chief Financial Officer

225,000

225,000

225,000

225,000

 

These awards are intended to align the incentives of the CEO, CFO and other senior employees with the Company's performance and outcomes for shareholders over the long term and to provide effective and attractive levels of reward to retain individuals who are key to the future success of the Company, based on delivering strong performance in a fair and proportionate manner.

 

Vesting will also normally be dependent on the continued employment of the participant within the Company's group. The awards are subject to market standard leaver, malus and clawback provisions.

 

The total four-year programme of awards comprising the Options and the Tranche 4 Options are intended to be up to 4,200,000 Ordinary Shares, representing 4.0 per cent. of the Company's current issued share capital. Following the grant of the four tranches, there will be total options outstanding over a total of 10,634,675 Ordinary Shares in the Company, representing 10.0 per cent. of the Company's current issued share capital.

 

The following notifications are intended to satisfy the Company's obligations under Article 19 of the UK Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James van den Bergh

James Hussey

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

Chief Financial Officer

b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

TruFin Plc

b)

LEI

213800C2QPZFECSRZ964

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares

Identification code

ISIN: JE00BYVWJZ03

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price

Volume

Nil

900,000

Nil

675,000

d)

Aggregated information:

Aggregated volume

Price

Single transaction as in 4c) above

1,575,000

Nil

e)

Date of the transaction

27 July 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

Enquiries:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 13400777 922 9508

 

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

Cara Murphy

0203 100 2000

About TruFin plc:

TruFin plc is the holding company of an operating group comprising four growth-focused technology businesses operating in niche markets: early payment provision, invoice finance, IFA finance and mobile games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKOBPOBKDKOB
Date   Source Headline
12th Apr 20247:01 amRNSBlock Admission Application
12th Apr 20247:00 amRNSGrant of share awards under LTIP
2nd Apr 20247:00 amRNSAppointment of Director to the Board of Playstack
26th Mar 20247:01 amRNSSale of Interact platform
25th Mar 20247:00 amRNSSatago signs contract with Bank of Ireland Finance
19th Mar 20247:00 amRNSNotice of Results and Investor Presentation
18th Mar 20247:00 amRNSPlaystack announces over 1m units sold for Balatro
12th Mar 202411:07 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSPlaystack releases its fastest selling game
8th Feb 20247:00 amRNSTrading Update
4th Jan 20247:00 amRNSTrading Update
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.